menu
    • menu

    Company profile for Umoja Biopharma

    NEW Drugs in Dev: 6
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Umoja is driven by a bold and unified vision to transform cancer treatment and improve quality of life. We are a diverse group of drug development experts, scientists and researchers that are skilled, passionate, persistent, and relentlessly committed to finding a way to break through the current challenges encountered in immuno-oncology. We also strive to foster a distinct culture that celebrates every team member’s divers...
    Umoja is driven by a bold and unified vision to transform cancer treatment and improve quality of life. We are a diverse group of drug development experts, scientists and researchers that are skilled, passionate, persistent, and relentlessly committed to finding a way to break through the current challenges encountered in immuno-oncology. We also strive to foster a distinct culture that celebrates every team member’s diverse set of skills and contributions. We believe our collective strengths and unique perspectives are what make Umoja a great place to work.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Umoja BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1920 Terry Ave Seattle, WA 98101
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.umoja-biopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/umoja-biopharma/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/UmojaBiopharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Umoja Biopharma Announces Unveiling of UB-VV500
    Umoja Biopharma Announces Unveiling of UB-VV500

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7211810

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    Umoja Bio Appoints Dr. Marcela Maus And Dr. Athena Countouriotis
    Umoja Bio Appoints Dr. Marcela Maus And Dr. Athena Countouriotis

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260504/0/en/Umoja-Biopharma-Appoints-Dr-Marcela-Maus-and-Dr-Athena-Countouriotis-to-Board-of-Directors.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    Umoja Bio Fast Tracks Ub-Vv111 For B-Cell Malignancies
    Umoja Bio Fast Tracks Ub-Vv111 For B-Cell Malignancies

    30 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/30/3158491/0/en/Umoja-Biopharma-Announces-that-UB-VV111-Receives-FDA-Fast-Track-Designation-for-Relapsed-Refractory-B-Cell-Malignancies.html

    GLOBENEWSWIRE
    30 Sep 2025
    Share Share
    Umoja Bio Among 2025's Top Biotechs By Endpoints News & Fierce
    Umoja Bio Among 2025's Top Biotechs By Endpoints News & Fierce

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154591/0/en/Umoja-Biopharma-Named-One-of-2025-s-Most-Promising-Biotech-Companies-by-Endpoints-News-and-Fierce-Biotech.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Umoja Bio Announces Appoints of Dr. Luke as Chief Medical Officer
    Umoja Bio Announces Appoints of Dr. Luke as Chief Medical Officer

    27 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/27/3015573/0/en/Umoja-Biopharma-Announces-Appointment-of-Dr-Luke-Walker-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    27 Jan 2025
    Share Share
    Umoja secures $100M series C to bring more CAR-Ts into clinic
    Umoja secures $100M series C to bring more CAR-Ts into clinic

    15 Jan 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/umoja-secures-100m-series-c-bring-more-car-ts-clinic

    FIERCE BIOTECH
    15 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search